Name Dana Sleiman
Title MD
Primary Specialty Endocrinology, Diabetes and Osteoporosis Consultant
Languages Arabic, English & French
Contact Details
Email [email protected]
Phone +974 4400 4400

Social Media

Scope of Practice

  • Diabetes & Obesity
  • Functional Medicine
  • Polycystic Ovary Syndrome (PCOS) & Hormonal Imbalances
  • Pituitary and Adrenal Diseases
  • Thyroid disease
  • Osteoporosis & calcium metabolism

Highlights

Academic Achievements:

0 +
Conferences
0 +
Research
0 +
Pro Courses

Community Outreach Activities/Achievements:

  • Featured in several TV interviews on local and regional channels: presented and participated in around 100 medical and social events
  • Participated in raising social & public awareness for Diabetes, Obesity and other endocrinological disorders as a Co-Founder of the Development Association for Arab Leadership & Innovation, Beirut, Lebanon

Health Care Profession Achievements:

  • +10 Years of Experience

Experience & Education

  • Endocrinology consultant, Beirut Lebanon
  • Functional Medicine Certificate -Institute of Functional Medicine (IFM) / USA
  • Specialty in Endocrinology & Diabetes Certificate –Royal College of Physicians London / England
  • Specialty in Endocrinology and Metabolism -Fellowship Program in Endocrinology & Metabolism Department of Endocrinology -American University of Beirut Medical Center (AUBMC) Beirut
  • Specialty in Internal Medicine Department of Internal Medicine Residency Program in Internal Medicine -American University of Beirut Medical Center (AUBMC) -Beirut
  • Doctor of Medicine (MD) School of Medicine American University of Beirut (AUB) -Beirut

Certifications & Memberships

  • Co-Founder –Development Association for Arab Leadership & Innovation / Beirut
  • Member –Lebanese Society of Endocrinology, Diabetes & Lipids
  • Member –Lebanese Order of Physicians
  • Member –Endocrine Society / USA
  • Member –Health 2.0 NYC- The New York Health Care Innovation Group/ USA
  • Member –Lebanese Society for Osteoporosis and Metabolic Bone Disorders / Beirut
  • Former Member –Lebanese Red Cross, (Youth Section) / Beirut

Publications

Most Recent

  • 12months,multicenter,non-interventional,prospective study to describe clinical outcomes after iGlarlixi initiation in patients with type 2 diabetes Research investigator 2020 {Sponsored by Sanofi}
  • Effect of Mediterranean Diet in Diabetes Control & Cardiovascular Risk Modification A Systematic Review / Feb 2017 Authors: Dana Sleiman, Marwa R Al Badri & Sami T Azar {Child Health and Human Development – Frontiers}
  • The effect of Magnesium Supplementation on Glucose Metabolism Reviewer of Randomized Controlled Trial - May 2016 {European Journal of Clinical Nutrition}
  • {OSTEOS Newsletter- Winter 2013} Guest Editor {Lebanese Society of Osteoporosis and Metabolic Bone Disease}
  • GLP (1) and macro vascular complications Authors Dana Sleiman and Sami T Azar / Jan 2012 {Journal of Diabetes and Metabolism}
See more publications
  1. Multinational open label randomized active controlled 3 arm parallel groups 24 weeks’ study comparing combination of glimepiride and metformin versus glimepiride and metformin alone in patients with type two diabetes. Research co-investigator 2013 {Sponsored by Sanofi- Aventis}
  2. Diabetes: From Etiology to Complications Data Collector & Analyst – {Prepared for Ministry of Social Affairs Workshop} 2013
  3. GLP 1 and Macrovascular Complications Data Collector & Analyst – 2012 {Prepared for the Journal of Diabetes and Metabolism}